Victoria Tear - Synairgen Plc Head Laboratory

SNG Stock   4.72  0.33  7.52%   

Executive

Victoria Tear is Head Laboratory of Synairgen plc
Phone44 23 8051 2800
Webhttps://www.synairgen.com

Synairgen Plc Management Efficiency

The company has return on total asset (ROA) of (0.3058) % which means that it has lost $0.3058 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4886) %, meaning that it generated substantial loss on money invested by shareholders. Synairgen Plc's management efficiency ratios could be used to measure how well Synairgen Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

EXECUTIVE Age

James HendersonLowland Investment Co
62
Georgi GanevKinnevik Investment AB
48
Ian WarmerdamBankers Investment Trust
N/A
Carrie PritchardEmpire Metals Limited
N/A
Laura FollLowland Investment Co
N/A
Tim StevensonBankers Investment Trust
N/A
Paul NivenFC Investment Trust
N/A
Jessica ThorellKinnevik Investment AB
41
Akhil ChainwalaKinnevik Investment AB
36
Alexander ASIPBankers Investment Trust
54
Samuel SjostromKinnevik Investment AB
37
Roddi VaughanThomasTatton Asset Management
N/A
Andrew BurnettLivermore Investments Group
N/A
Justine RandallTatton Asset Management
N/A
Michael KerleyBankers Investment Trust
58
Louisa StokesEmpire Metals Limited
N/A
Louise ColemanTatton Asset Management
N/A
Anna StenbergKinnevik Investment AB
45
Alexander CrookeBankers Investment Trust
54
Michael WoodMartinBankers Investment Trust
N/A
Mattias AnderssonKinnevik Investment AB
48
Synairgen plc (SNG) is traded on London Exchange in UK and employs 36 people.

Management Performance

Synairgen plc Leadership Team

Elected by the shareholders, the Synairgen Plc's board of directors comprises two types of representatives: Synairgen Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synairgen. The board's role is to monitor Synairgen Plc's management team and ensure that shareholders' interests are well served. Synairgen Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synairgen Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pr Djukanovic, CoFounder Board
Gareth Walters, Chief Officer
Richard Francis, Senior Quality
Jody Brookes, Senior Operations
Joseph FCA, CFO Director
Phillip Monk, Chief Board
Victoria Tear, Head Laboratory
Richard Marsden, MD CEO
Pr Davies, CoFounder Board
MD CBE, NonExecutive CoFounder

Synairgen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synairgen Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Synairgen Stock

Synairgen Plc financial ratios help investors to determine whether Synairgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Synairgen with respect to the benefits of owning Synairgen Plc security.